Lori Hu

Lori Hu is a seasoned professional in the healthcare and biotechnology sectors, currently serving as Managing Director at Vertex Ventures HC since August 2015. Lori's extensive board leadership experience includes roles as Board Director for multiple companies, such as SonoThera, Palleon Pharmaceuticals, Indapta Therapeutics, Neuspera Medical Inc., and Elevation Oncology, where responsibilities encompass overseeing innovative treatments in oncology, immune regulation, and neuromodulation. Additionally, Lori holds a position as Board Observer at TORL BioTherapeutics, LLC, and brings prior experience as a VC Associate at S.R. One Ltd. Academic credentials include an M.B.A. from The Wharton School, a Master's Degree in International Studies from The Lauder Institute, and a Bachelor of Science in Biomedical Engineering from Duke University.